Invesco Biotechnology & Genome ETF
PBE
#2137
ETF Rang
€0.21 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
68,95 €
Aktienkurs
0.39%
Veränderung (1 Tag)
26.25%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 3. Mai 2026Anzahl der Bestände: 32

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
6.26%
United Therapeutics CorpUTHR27212
5.74%
Illumina IncILMN104832
4.98%
Incyte CorpINCY127499
4.98%
Biogen IncBIIB66025
4.72%
Regeneron Pharmaceuticals IncREGN16684
4.63%
Gilead Sciences IncGILD87264
4.62%
Alnylam Pharmaceuticals IncALNY38706
4.47%
Amgen IncAMGN33651
3.42%
BioCryst Pharmaceuticals IncBCRX923458
3.37%
Catalyst Pharmaceuticals IncCPRX290513
3.33%
Arrowhead Pharmaceuticals IncARWR110374
3.19%
Protagonist Therapeutics IncPTGX80415
3.16%
CareDx IncCDNA365065
3.14%
TG Therapeutics IncTGTX230335
3.09%
Royalty Pharma PLCRPRX154791
2.85%
Neurocrine Biosciences IncNBIX53660
2.74%
Exelixis IncEXEL155682
2.71%
Bio-Techne CorpTECH122004
2.68%
PTC Therapeutics IncPTCT101877
2.63%
Vericel CorpVCEL183726
2.63%
Veracyte IncVCYT196903
2.58%
Halozyme Therapeutics IncHALO99880
2.53%
ACADIA Pharmaceuticals IncACAD285787
2.50%
Ionis Pharmaceuticals IncIONS82240
2.50%
Theravance Biopharma IncTBPH368704
2.47%
Repligen CorpRGEN52183
2.45%
BioMarin Pharmaceutical IncBMRN112225
2.15%
Collegium Pharmaceutical IncCOLL155578
2.00%
QIAGEN NVQGEN144898.3786
1.45%
MannKind CorpMNKD1268504
0.06%
Invesco Government & Agency PortfolioAGPXX146277.13
0.00%
CASH & EQUIVALENTSUSD5728